Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1)

International Journal of Biochemistry and Cell Biology

Volumn 33, Issue 4, 2001, Pages 409-420

  Shibuya, Masabumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Angiogenesis; Immunoglobulin (Ig); Neovascularization; Vascular endothelial growth factor (VEGF); Vasculogenesis

Indexed keywords

IMMUNOGLOBULIN; LIGAND; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; BINDING AFFINITY; CELL MIGRATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ORGANIZATION; MACROPHAGE; MONOCYTE; NONHUMAN; PROTEIN DOMAIN; RECEPTOR BINDING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; DNA; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 0035059209     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(01)00026-7     Document Type: Review

References (69)

1. Mechanism of angiogenesis
2. Blood vessel formation: What is its molecular basis?
3. The biology of vascular endothelial growth factor
4. Role of VEGF-Flt receptor system in normal and tumor angiogenesis
5. Endothelial receptor tyrosine kinases involved in angiogenesis
6. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
7. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
8. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4
9. Structure and function of VEGF receptor-1 and -2
10. Identification of a new endothelial cell growth factor receptor tyrosine kinase
11. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit
12. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor
13. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family
14. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
15. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction
16. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1
17. Characterization of the extracellular domain in the vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase)
18. The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade
19. Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability
20. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor
21. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors
22. SH2 domains recognize specific phosphopeptide sequences
23. Characterization of the promoter region for flt-1 tyrosine kinase gene, a receptor for vascular endothelial growth factor
24. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
25. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors
26. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity
27. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and tis heterodimerization with KDR
28. Evidence for an ancestral immunoglobulin gene coding for half a domain
29. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1)
30. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells
31. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells
32. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues
33. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene
34. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes
35. Migration of human monocytes in response to vascular endothelilal growth factor (VEGF) is mediated via the VEGF receptor flt-1
36. The vascular endothelial growth factor receptor Flt-1 madiates biological activities
37. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor
38. Specificity of vascular endothelial cell growth factor receptor ligand binding domains
39. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor (PlGF), which is related to vascular endothelial growth factor (VEGF)
40. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
41. VEGF-B binds to VEGFR-1 and regulates plasminogen activator activity in endothelial cells
42. Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique
43. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
44. Neuropilin-1 is a placenta growth factor-2 receptor
45. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic
46. A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
47. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases
48. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
49. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption
50. Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes
51. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis
52. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
53. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
54. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
55. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
56. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
57. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice
58. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
59. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
60. The phosphorylated 1169-tyrosine containing region of Flt-1 kinase (VEGFR-1) is a major binding site for PLCγ
61. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules
62. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLCγ pathway and partially induces mitotic signals in NIH3T3 fibroblasts
63. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells
64. Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials
65. An oncogenic form of the Flt-1 kinase has a tubulogenic potential in a sinusoidal endothelial cell line
66. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
67. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor
68. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2
69. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate